Insider Transaction Overview
Neuronetics Inc. (NASDAQ:STIM) director and 10 % owner Jorey Chernett filed a Form 4 indicating a series of transactions between 6 November and 13 November 2026. Over that period he sold a total of 3,335,411 common shares for approximately $4.48 million and simultaneously purchased 40,000 shares for $79,600.
The sales were executed at weighted‑average prices ranging from $1.15 to $2.39 per share. On 6 November he sold 250,804 shares at a weighted average of $2.39 (range $2.16‑$2.56). On 9 November he sold 103,959 shares at $2.06 average (range $1.96‑$2.18) and bought 40,000 shares at $1.99 average (range $1.98‑$2.00). Further sales included 86,757 shares on 11 November at $1.61 average (range $1.59‑$1.65), 706,840 shares on 12 November at $1.43 average (range $1.39‑$1.54), and the largest block of 2,187,051 shares on 13 November at $1.15 average (range $1.15‑$1.44).
Following the transactions Chernett beneficially owns 7,325,577 shares of Neuronetics. The filing notes that the trades are “matchable transactions” subject to Section 16(b) of the Securities Exchange Act of 1934, and Chernett intends to disgorge any short‑swing profit, designating the filing as an “exit filing.”
Market context: InvestingPro data show STIM shares fell 35 % over the prior week, trading at $1.39, roughly 60 % below the 52‑week high of $3.44. Analysts maintain price targets between $5 and $7, indicating perceived upside.
In related news, Neuronetics reported third‑quarter 2026 results that beat expectations. The company posted a loss of $0.02 per share versus the consensus loss of $0.09, and revenue of $42 million exceeded the forecast of $40.43 million, reflecting stronger margins and progress toward profitability.